/
/
/

Jagsonpal Pharmaceuticals Balance Sheet

Consolidated
Standalone
%

Share Price Live Stats

Open (₹)242.00
Volume (₹)56,210.00
High (₹)242.27
Upper Circuit286.82
Low (₹)238.88
Lower Circuit191.22
Prev Close243.02
52W High (₹)264.50
Price239.41
52W Low (₹)155.00

Share Market Cap & Key Ratios Overview

M.Cap (₹)1600.13 Cr
Div. Yield (%)2.27
PE Ratio35.19
Debt to Equity0.00
Price to Book4.83
Book Value38.18
EPS (TTM)6.89
Face Value2.00
ROE (%)18.19

Stock Analysis (SWOT)

StrengthsWeaknessesOpportunitiesThreats
1. Premium insight available after login
2. Sign in to view full SWOT analysis
3. Unlock strengths, weaknesses, opportunities & threats
Sign in to view
Open a free Demat account in minutes to start investing and screening .

QVT

Quality
0/100-
Valuation
0/100-
Technical
0/100-
Sign in to view
Open a free Demat account in minutes to start investing and screening .

Peer Stocks

1 week
1 month
1 year
Name
SUNPHARMANSE
DIVISLABNSE
TORNTPHARMNSE
ZYDUSLIFENSE
CIPLANSE
LAURUSLABSNSE
LUPINNSE
MANKINDNSE
DRREDDYNSE
AUROPHARMANSE
JAGSNPHARMNSE
LTP
1W Low
1W High
Market cap (₹)
1901.6-18.4 (-0.96%)
1900.10
1984.80
4,56,833Cr
9180-59 (-0.64%)
9087
9467
2,45,426Cr
4859.5-190.5 (-3.77%)
4857
5066
1,87,320Cr
1131.7-59.3 (-4.98%)
1125.10
1187
1,13,217Cr
1380.7-42.8 (-3.01%)
1376.70
1426.10
1,12,212Cr
1853.6-84.9 (-4.38%)
1811.70
1949
1,01,155Cr
2123-48.5 (-2.23%)
2118.10
2192
97,626Cr
2335.2-47.7 (-2.00%)
2335
2419.20
96,859Cr
1162.3-15.7 (-1.33%)
1154.40
1179.90
96,406Cr
1657.8+12.5 (0.76%)
1622.60
1717
93,614Cr
239.41+0.35 (0.15%)
235.50
249.57
1,600Cr

Key Highlights of Jagsonpal Pharmaceuticals Ltd Balance Sheet

Jagsonpal Pharmaceuticals Ltd balance sheet discloses shareholders' funds of ₹13.39Cr as of 2026-03-31. The company’s equity share capital is at a value of ₹13.39Cr, and the reserves and surplus of the company is ₹242.3Cr.

The company has its non-current liabilities with total liabilities of ₹329.3Cr as of 2026-03-31.

The current liabilities are ₹40.92Cr as of 2026-03-31. At the same time, current assets are ₹155.71Cr as of 2026-03-31.

Key assets on the balance sheet are non-current investments of 0 and tangible assets of ₹85.31Cr, provided in the Jagsonpal Pharmaceuticals Ltd financial statements.